IPHA

Innate Pharma

7 hedge funds and large institutions have $760K invested in Innate Pharma in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$242K +$220K +50,980 +994%
Millennium Management
2
Millennium Management
New York
$214K -$21.4K -4,963 -9%
Optiver Holding
3
Optiver Holding
Netherlands
$131K +$131K +30,284 New
Citadel Advisors
4
Citadel Advisors
Florida
$109K +$109K +25,250 New
LPL Financial
5
LPL Financial
California
$52K +$52K +12,000 New
Osaic Holdings
6
Osaic Holdings
Arizona
$9K +$9K +2,000 New
SPIA
7
Steward Partners Investment Advisory
New York
$2.8K -$1.94K -450 -41%
Wellington Management Group
8
Wellington Management Group
Massachusetts
-$5.46M -1,334,652 Closed